Allergan urges shareholders to reject Valeant Pharmaceuticals takeover offer

MONTREAL – Allergan Inc. urged its shareholders Monday to reject a hostile takeover offer by Valeant Pharmaceuticals International Inc. (TSX:VRX). Valeant, which had tried to negotiate a deal to acquire Allergan, took its offer directly to the company’s shareholders last week.

News from © The Canadian Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

The Canadian Press

The Canadian Press is Canada's trusted news source and leader in providing real-time, bilingual multimedia stories across print, broadcast and digital platforms.